abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

このページは 日本語 では利用できません。English で表示されています

記事

2007年1月25日

著者:
Nopporn Wong-Anan, Scientific American

Thailand stuns drug firms with generic licenses

Thailand's army-installed government has issued licenses for cheap generic versions of a heart disease and an AIDS drug...Drug companies reacted angrily to the announcement…and urged [the health minister] to reconsider a decision they said could lead to many firms leaving the country…[The health minister] declined to confirm newspaper reports [that] they were Abbott Laboratories' Kaletra, and Plavix… sold by Sanofi-Aventis and Bristol-Myers Squibb. [also mentions Merck]